What is the primary purpose of augmentation therapy?
Augmentation therapy infusions are intended to increase or augment the amount of alpha-1 antitrypsin (AAT) available in the blood to bathe the tissues of the body in individuals with Alpha-1-related lung disease. Some individuals report that they notice improvements in their health when on augmentation therapy, and there is some evidence for a decrease in the number of lung infections in individuals receiving augmentation therapy. Yet the primary aim of this therapy is to reduce the rate of decline of lung function, and, therefore, improve the long-term quality of life and even the lifespan of individuals with Alpha-1.
Augmentation therapy infusions are intended to increase or augment the amount of alpha-1 antitrypsin (AAT) available in the blood of individuals with Alpha-1-related lung disease. Some individuals report that they notice improvements in their health when on augmentation therapy, and there is some evidence for a decrease in the number of lung infections in individuals receiving augmentation therapy. Yet the primary aim of this therapy is to reduce the rate of decline of lung function and, therefore, improve the long-term quality of life and even the lifespan of individuals with Alpha-1.
